Indication
Emerging Fungi
1 clinical trial
1 product
Product
IbrexafungerpClinical trial
Open-Label Study to Evaluate the Efficacy and Safety of SCY-078 (Ibrexafungerp) in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment (FURI)Status: Completed, Estimated PCD: 2023-08-17